Valneva SE (VALN) Free Cash Flow (2021 - 2026)

Valneva SE (VALN) posted quarterly Free Cash Flow of -$73967.0 for Q1 2026, up 98.97% year-on-year from -$37174.3 in Q1 2025, and up 99.81% on a QoQ basis from -$39.1 million in Q4 2025.

Valneva SE (VALN) Free Cash Flow (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Free Cash Flow for 6 consecutive years, with -$73967.0 the latest figure, recorded in Q1 2026.

  • Quarterly Free Cash Flow rose 98.97% year-over-year to -$73967.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.1 million (up 19.76% YoY) and the FY2025 annual result came in at -$65.2 million, up 29.31% from the prior year.
  • Free Cash Flow improved to -$73967.0 in Q1 2026 per VALN's latest filing, from -$39.1 million in the prior quarter.
  • Over the last five years, Free Cash Flow for VALN reached as high as $65.4 billion in Q3 2023 and fell as low as -$65.6 billion in Q2 2023.
  • A 5-year average of -$42.2 million and a median of -$22.8 million in 2023 frame the typical range for Free Cash Flow.
  • The largest YoY upside for Free Cash Flow was 69794.7% in 2023 against a maximum downside of 87190.81% in 2023.
  • Year by year, Free Cash Flow stood at -$123.6 million in 2022, then advanced by 17.7% to -$101.7 million in 2023, then soared by 82.21% to -$18.1 million in 2024, then plunged by 115.88% to -$39.1 million in 2025, then soared by 99.81% to -$73967.0 in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$73967.0, -$39.1 million, and -$17.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -73,967.03

Historic Data

Download Data
DateValue
Mar 31, 2026 -73,967.03
Mar 31, 2026 -73,967.03
Dec 31, 2025 -39.07 Mn
Dec 31, 2025 -39.07 Mn
Sep 30, 2025 -17.39 Mn
Sep 30, 2025 -17.39 Mn
Jun 30, 2025 -1.56 Mn
Jun 30, 2025 -1.56 Mn
Mar 31, 2025 -7.21 Mn
Mar 31, 2025 -7.21 Mn
Dec 31, 2024 -18.10 Mn
Dec 31, 2024 -18.10 Mn
Sep 30, 2024 -4.70 Mn
Sep 30, 2024 -4.70 Mn
Jun 30, 2024 -42.38 Mn
Jun 30, 2024 -42.38 Mn
Mar 31, 2024 -27.09 Mn
Mar 31, 2024 -27.09 Mn
Dec 31, 2023 -101.74 Mn
Dec 31, 2023 -101.74 Mn